Biotech mergers and acquisitions remain strong with billion-dollar-scale deals even in the era of AI unicorns
Against the backdrop of rapid growth of AI unicorn companies, the biotechnology industry has consolidated its market position through mergers and acquisitions, with transaction volumes exceeding $38 billion in the past two years. Although the proportion of financing has decreased, major acquisitions are still underway, and industry performance remains stable, creating conditions for sustainable development.
TechubNews·02-18 12:42


